Code of the District of Columbia

Subchapter VII-F. Qualifications for Licensure to Practice as a Clinical Laboratory Practitioner.


§ 3–1207.61. Qualifications for licensure.

(a) The Board of Pharmacy shall license as a cytotechnologist a person who, in addition to meeting the requirements of subchapter V of this chapter, has:

(1) At least a baccalaureate degree from an accredited institution that incorporates the academic coursework and minimum hours of supervised training required by the regulations adopted by the Board and whose program is accredited by an agency recognized by the U.S. Department of Education, or has qualified as a cytotechnologist under federal regulations; and

(2) Passed a national certification examination given by the Board or from a body recognized by the Board.

(b) The Board of Pharmacy shall license as a histologic technician a person who, in addition to meeting the requirements of subchapter V of this chapter, has demonstrated, to the satisfaction of the Board, that he or she possesses the medical laboratory education, training, or experience that is appropriate for medical laboratory technicians concentrating in histology.

(c) The Board of Pharmacy shall license as a histotechnologist a person who, in addition to meeting the requirements of subchapter V of this chapter, has:

(1)(A) At least a baccalaureate degree in biological sciences and chemistry from an accredited institution recognized by the U.S. Department of Education; or

(B) Successfully completed a histotechnology program accredited by an agency recognized by the U.S. Department of Education or one year of full-time laboratory work experience in histology deemed acceptable by the Board of Pharmacy; and

(2) Passed a national certification examination given by the Board or from a body recognized by the Board.

(d) The Board of Pharmacy shall license as a medical laboratory technician a person who, in addition to meeting the requirements of subchapter V of this chapter, has:

(1) Successfully completed a medical laboratory technician program accredited by an agency recognized by the U.S. Department of Education or a military medical laboratory specialists program;

(2) Obtained an associate degree or has at least 60 semester hours or 90 quarter hours from an accredited institution recognized by the U.S. Department of Education, including a minimum of 6 semester hours or 9 quarter hours of biological science and 6 semester hours or 9 quarter hours of chemical science, and has 3 years of full-time acceptable medical laboratory work experience within the last 5 years; or

(3) Been previously qualified as a medical laboratory technologist under federal regulations; and

(4) Passed a national certification examination given by the Board or from a body recognized by the Board.

(e)(1) The Board of Pharmacy shall license as a medical technologist a person who, in addition to meeting the requirements of subchapter V of this chapter, has:

(A) At least a baccalaureate degree from an accredited institution that includes courses in biological science, chemistry, and mathematics, and has successfully completed a medical technology program accredited by an agency recognized by the U.S. Department of Education;

(B) A baccalaureate degree from a regionally accredited institution recognized by the U.S. Department of Education, including a minimum of 16 semester hours or 24 quarter hours of biological science, 16 semester hours or 24 quarter hours of chemical science, including one semester or one quarter in organic chemistry or biochemistry, one semester or one quarter of mathematics, and 3 years of full-time, clinical laboratory work experience in the major disciplines of laboratory practice deemed acceptable by the Board of Pharmacy, within the last 5 years and one of the following:

(i) Certification as a medical laboratory technologist by a national certifying organization acceptable to the Board;

(ii) Successful completion of a medical laboratory technology program accredited by an agency recognized by the U.S. Department of Education; or

(iii) Successful completion of an advanced military medical laboratory specialist program;

(C) A baccalaureate degree from an accredited institution, including a minimum of 16 semester hours or 24 quarter hours of biological science, 16 semester hours or 24 quarter hours of chemical science, including one semester or one quarter in organic chemistry or biochemistry, one semester or one quarter of mathematics, and 5 years of full- time clinical laboratory work experience in the major disciplines of laboratory practice deemed acceptable by the Board of Pharmacy, within the last 10 years; or

(D) Been previously qualified as a medical technologist under federal regulations, or has a baccalaureate degree and training or experience as the Board determines is appropriate for medical technologists concentrating in categories such as blood banking, chemistry, hematology, immunology, microbiology, and virology; and

(E) Passed a national certification examination given by the Board or from a body recognized by the Board.

(2) For the purposes of this subsection, the term “major disciplines of laboratory practice” includes blood banking, chemistry, immunology, and microbiology.


(March 25, 1986, D.C. Law 6-99, § 761; as added May 2, 2015, D.C. Law 20-272, § 2(f), 62 DCR 1911.)


§ 3–1207.62. Waiver.

The Board shall waive the requirements specified in §  3-1207.61 for any cytotechnologist, histologic technician, histotechnologist, medical laboratory technician, or medical technologist who has passed an examination required by the Board, and who has received a certification from a national certifying organization acceptable to the Board that has current eligibility requirements that are equivalent to or exceed the qualifications established under this chapter.


(March 25, 1986, D.C. Law 6-99, § 762; as added May 2, 2015, D.C. Law 20-272, § 2(f), 62 DCR 1911.)


§ 3–1207.63. Exemption from licensure for select clinical laboratory practitioners.

(a) Section §  3-1210.01 shall not apply to a cytotechnologist, histotechnologist, medical laboratory technologist, medical technologist, histologic technician, or phlebotomist who is:

(1) Licensed or registered in the District of Columbia under any other act and who engages in the practice for which he or she is licensed or registered;

(2) Employed by the United States government or any bureau, division, or agency thereof while in the discharge of the employee’s official duties;

(3) Engaged exclusively in education or research; provided, that the results of any examination performed are not used in the diagnosis, prevention, or treatment of a disease, or assessment of a medical condition;

(4) A student or trainee enrolled in a medical laboratory education program; provided, that the activities constitute a part of a planned course in the program, the person is designated by a title such as intern, trainee, or student, and the person works directly under a person licensed under § 3-1207.61;

(5) Exclusively performing laboratory tests, classified as waived pursuant to 42 CFR § 493, which are determined by the Secretary of the U.S. Department of Health and Human Services to have an insignificant risk of an erroneous result, including those which:

(A) Have been approved by the United Stated Food and Drug Administration;

(B) Employ methodologies that are so simple and accurate as to render the likelihood of erroneous results negligible; or

(C) The Secretary of the U.S. Department of Health and Human Services has determined pose no reasonable risk of harm to the patient if performed incorrectly;

(6) A pathologist or other licensed physician;

(7) A laboratory manager who does not perform or supervise laboratory tests; or

(8) Performing point-of-care testing; provided, that:

(A) A laboratory director, or other licensed individual to whom the laboratory director has delegated his or her duties as a laboratory director, provides oversight and is responsible for ensuring the development and implementation of:

(i) A protocol of implementation, including tests to be performed and staff who will perform the tests;

(ii) Criteria to be used in selecting the method of testing to be used for point-of-care testing;

(iii) Minimum training and education requirements for those who will perform point-of-care testing;

(iv) Documented in-service training, initial and ongoing competency validation of personnel performing point-of-care testing;

(v) An appropriate internal and external quality control protocol; and

(vi) Record keeping requirements; and

(B) Processes are in place and are acceptable to the Board that ensure and document the continued competency of point-of-care testing personnel.

(b) For the purposes of this section, the term

(1) “Laboratory director” means:

(A) A physician or dentist who is qualified and eligible to supervise and direct the technical and scientific operation of a medical laboratory by possessing the following:

(i) Certification in anatomic or clinical pathology, or both, by the American Board of Pathology, the American Osteopathic Board of Pathology, or qualifications that are equivalent to those required for certification;

(ii) Certification by the American Board of Pathology or the American Osteopathic Board of Pathology in at least one of the laboratory specialties;

(iii) Certification by the American Board of Medical Microbiology, the American Board of Clinical Chemistry, the American Board of Bioanalysts, or another national accrediting board in at least one of the laboratory specialties;

(iv) Certification by the American Society of Cytopathology to practice cytopathology or qualifications that are equivalent to those required for certification;

(v) Subsequent to graduation, 4 or more years of full-time general laboratory training or experience, of which at least 2 years were spent acquiring proficiency in one of the laboratory specialties in a licensed medical laboratory; or

(vi) Subsequent to graduation, other documented clinical laboratory training and experience as the Board determines by regulation is appropriate, taking into consideration the complexity and diversity of the laboratory tests to be performed; or

(B) A dentist, certified by the American Board of Oral Pathology for the specialty of oral pathology only, or qualifications which are equivalent to those required for certification.

(2) “Point-of-care testing” means analytical patient-testing activities that are performed under the supervision of the laboratory director within an institution, but are performed outside the physical facilities of the central medical laboratory and do not require permanent dedicated space, and include the use of analytical instruments that are temporarily brought to a patient care location.


(March 25, 1986, D.C. Law 6-99, § 763; as added May 2, 2015, D.C. Law 20-272, § 2(f), 62 DCR 1911.)


§ 3–1207.64. Transition of licensed and registered clinical laboratory practitioners.

For a period of 2 years after May 2, 2015, all references in this chapter to “clinical laboratory practitioners” shall be deemed to refer to persons meeting the requirements for licensure or registration in the District of Columbia, regardless of whether that person is licensed or registered.


(March 25, 1986, D.C. Law 6-99, § 764; as added May 2, 2015, D.C. Law 20-272, § 2(f), 62 DCR 1911.)